A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Clinical trial NCT01275105 · COMPLETED
Trial details
- NCT number
- NCT01275105
- Sponsor
- Eye Therapies, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-03-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.